Wikidata entity: Q416206
C₁₉H₂₄N₄O₂ (P274)
Quantities
| P2067 | mass | 340.19 |
| P3780 | active ingredient in | ... | Q47521876 (NebuPent) | NebuPent |
| P233 | canonical SMILES | String | C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N | ??? |
| P373 | Commons category | String | Pentamidine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q353172 (parasitic protozoa infectious disease) | parasitic protozoa infectious disease |
| P2175 | medical condition treated | ... | Q331283 (leishmaniasis) | leishmaniasis |
| P2175 | medical condition treated | ... | Q7205993 (pneumocystosis) | pneumocystosis |
| P2175 | medical condition treated | ... | Q2046113 (visceral leishmaniasis) | visceral leishmaniasis |
| P2175 | medical condition treated | ... | Q2443552 (trypanosomiasis) | trypanosomiasis |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q41576 (cocaine) | cocaine |
| P769 | significant drug interaction | ... | Q58375 (thioridazine) | thioridazine |
| P769 | significant drug interaction | ... | Q58376 (fluphenazine) | fluphenazine |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q165399 (azithromycin) | azithromycin |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q412496 (quinidine) | quinidine |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410011 (ondansetron) | ondansetron |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q415843 (sulfamethoxazole) | sulfamethoxazole |
| P769 | significant drug interaction | ... | Q417204 (levomepromazine) | levomepromazine |
| P769 | significant drug interaction | ... | Q420387 (foscarnet) | foscarnet |
| P769 | significant drug interaction | ... | Q421381 (flecainide) | flecainide |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q417597 (procainamide) | procainamide |
| P769 | significant drug interaction | ... | Q417909 (terfenadine) | terfenadine |
| P769 | significant drug interaction | ... | Q419394 (sevoflurane) | sevoflurane |
| P769 | significant drug interaction | ... | Q425295 (cisapride) | cisapride |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q423437 (astemizole) | astemizole |
| P769 | significant drug interaction | ... | Q423757 (escitalopram) | escitalopram |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q422438 (chloroquine) | chloroquine |
| P769 | significant drug interaction | ... | Q422665 (trimethoprim) | trimethoprim |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q6821618 (mesoridazine) | mesoridazine |
| P769 | significant drug interaction | ... | Q7914515 (vandetanib) | vandetanib |
| P769 | significant drug interaction | ... | Q10354103 (probucol) | probucol |
| P769 | significant drug interaction | ... | Q947595 (halofantrine) | halofantrine |
| P769 | significant drug interaction | ... | Q976559 (sparfloxacin) | sparfloxacin |
| P769 | significant drug interaction | ... | Q3712521 (dofetilide) | dofetilide |
| P769 | significant drug interaction | ... | Q3791612 (ibutilide) | ibutilide |
| P769 | significant drug interaction | ... | Q3896970 (pasireotide) | pasireotide |
| P769 | significant drug interaction | ... | Q4890934 (bepridil) | bepridil |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q578726 (antifungal) | antifungal |
| P2868 | subject has role | ... | Q582559 (antiprotozoal) | antiprotozoal |
| P2868 | subject has role | ... | Q804539 (bactericide) | bactericide |
| P2868 | subject has role | ... | Q50430185 (trypanocidal agent) | trypanocidal agent |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | pentamidine | ??? |
Why not click here or view trends?
log id: 2069056